CME Activity

Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials

Course Directors

William D. Carey, MD

Director, Center for Continuing Education
Cleveland Clinic
Cleveland, Ohio

Kirsten Patrick

Assistant Editor, British Medical Journal, London

Faculty

Rémy Boussageon

General practitioner,
Lecturer in General Practice,
Department of General Medicine, Lyon University, France

Théodora Bejan-Angoulvant

Cardiologist, pharmacologist, and lecturer,
Lyon University Hospital and the University of Medicine,
Lyon, France

Mitra Saadatian-Elahi

Epidemiologist, Lyon University Hospital, France

Sandrine Lafont

Resident family medicine,
Department of General Medicine,
Lyon University, France

Claire Bergeonneau

Resident in family medicine,
Department of General Medicine,
Lyon University, France

Behrouz Kassaï

Pharmacologist and lecturer,
Clinical research, Lyon University Hospital, France

Sylvie Erpeldinger

General practitioner and lecturer,
General medicine,
Lyon University Hospital, France

James M Wright

Anaesthetist, pharmacologist, and professor,
Departments of Anaesthesiology, Pharmacology,
and Therapeutics and Medicine,
University of British Columbia, Vancouver, Canada

François Gueyffier

Cardiologist and professor and head,
Department of Clinical Pharmacology,
Lyon Hospital, France;
Head, Clinical Investigation Centre,
Lyon University Hospital, France

Catherine Cornu

Endocrinologist and pharmacologist,
Clinical Investigation Centre,
Lyon University Hospital, France

Accredited by

BMJ Learning

Course Description

Learning outcomes:
1) Identify the association between intensive glucose lowering strategy and risk of death from any cause, cardiovascular death, myocardial infarction, and other cardiovascular events; 2) Identify the association between intensive glucose lowering strategy and microvascular complications of diabetes; 3) Recognise the side effects of intensive glucose lowering strategy; 4) Recognise the methodological strengths and weaknesses of this meta-analysis.

Activity Details

Credit Types:	CME
Credit Amount:	1.0 Credits
Release Date:	2011-Jul-25
Expiration Date:	2013-Jul-25
Registration Required:	Yes
Cost:	£81/yr

Suggest a CME Activity

[x]

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

[x]

Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

[x]

Feedback